Name: Acute Care
Brand: ECRI
SKU: NIL
Availability: InStock
Rating: 4.6 (5 reviews)

ISMP Newsroom

ISMP

Media Inquiries

For media inquiries and interviews with ISMP's subject matter experts, please contact Renee Brehio at rbrehio@ismp.org.

Press Coverage

Press Coverage

Beware of Risks Regarding Medication Noncompliance

This article appeared on the ED Management website on October 1, 2023.

Press Coverage

Press Coverage

A Better Way to Evaluate Prefilled Syringes

This article appeared on the Outpatient Surgery Magazine website on September 18, 2023.

Press Coverage

Press Coverage

Safety of Anesthetic and Perioperative Medication Practices

This article appeared on the Pharmacy Practice News website on September 15, 2023.

Press Coverage

Press Coverage

12 Hospital Departments Ranked by Supply Shortages

This article appeared on the Becker’s Hospital Review website on September 8, 2023.

Press Coverage

Press Coverage

Picking Up a Prescription? 6 Tips to Avoid Dangerous Pharmacy Errors

This article appeared on the LA Times website on September 5, 2023.

Press Coverage

Press Coverage

Price Gouging of Cancer Drugs in Short Supply Hits Some Hospitals Hard

This article appeared on the MSN website on August 17, 2023.

Stay Connected

Get medication safety news, event invitations and updates straight to your inbox!

Social Media

View the Latest from ECRI

News

HANYS Marketplace partners with ECRI to improve patient safety and reduce preventable harm in healthcare

HANYS Marketplace® has partnered with ECRI, a nonprofit organization advancing the safety and quality of healthcare, to provide New York’s hospitals and health systems with evidence-based solutions...

News

ECRI Names Cottage Health Winner of 2026 Health Technology Excellence Award

Innovative blood management initiative recognized for reducing waste through proactive interfacility transfers. ECRI, a nonprofit organization advancing the safety and quality of healthcare, has ho...

News

ECRI & ISMP Statement in Response to PCAC Decision on Compounding Peptides

The FDA Pharmacy Compounding Advisory Committee (PCAC) decided to recommend adding most of the peptides under consideration during its July 23-24, 2026, meeting to the 503A Bulks List, despite subs...

View all